Quick summary

Plantago major (Plantain) is a medicinal plant traditionally used for a variety of conditions including wound healing and oral health. Clinical evidence is emerging but currently limited. Randomized clinical trials and systematic reviews suggest potential benefits in reducing menstrual bleeding severity, managing oral mucositis in cancer therapy, and promoting wound healing including diabetic foot ulcers. However, the quality of evidence varies and further rigorous clinical trials are needed to confirm efficacy and safety. Plantain extracts are also part of phytotherapy approaches in oral health and show promise in improving periodontal conditions. The safety profile in pregnancy and breastfeeding is not well established.

What is it

Plantain, scientifically known as Plantago major, is a perennial herb widely found in temperate regions. It has broad leaves and has long been used in traditional medicine systems around the world. Preparations can include leaves and seeds, used topically or orally, in various forms such as extracts, teas, and ointments.

Traditional uses

Traditionally, Plantain has been used for wound healing, skin conditions, respiratory ailments, and oral health maintenance. It has been applied topically to minor wounds, burns, and insect bites due to its soothing properties. Oral use includes treatment of mouth sores and inflammation. It has also been used to support menstrual health and gastrointestinal conditions.

Active compounds

Plantago major contains several bioactive compounds including iridoid glycosides (e.g., aucubin), polysaccharides, flavonoids, tannins, and phenolic acids. These compounds are believed to contribute to its anti-inflammatory, antimicrobial, antioxidant, and wound healing properties observed in preclinical studies.

Potential benefits with evidence levels

  • Reduction of high menstrual bleeding in women: Systematic review of randomized clinical trials reports significant findings for seed and leaf extracts in reducing duration and severity of bleeding and improving hematological parameters. [Source]
  • Management and reduction of radiation and chemotherapy-induced oral mucositis: Systematic reviews including randomized controlled trials suggest that Plantago major preparations may reduce severity and symptoms of oral mucositis in cancer patients undergoing radiotherapy or chemotherapy. [Source], [Source], [Source]
  • Wound healing including diabetic foot ulcers: Systematic reviews and meta-analyses of randomized controlled trials indicate potential benefits of Plantago major and related herbal products in wound healing and diabetic foot ulcers with improved healing metrics, though some studies report methodological limitations. [Source], [Source], [Source]
  • Improvements in oral health conditions such as periodontal disease: Reviews and clinical studies suggest Plantago major may contribute antimicrobial, anti-inflammatory, and healing effects, supporting improved periodontal parameters like plaque pH and bacterial counts. [Source], [Source], [Source]
  • Potential neuroprotective and anti-inflammatory effects: Preclinical studies and network pharmacology models indicate bioactive compounds in Plantago major may interact with inflammation and neurodegeneration pathways relevant to diseases such as Alzheimer’s. Clinical translation is limited. [Source]

Side effects

Reported adverse effects are minimal in existing clinical trials but data are insufficient for conclusive safety profiling. Some users of Plantago major preparations may experience mild local reactions, taste disturbances, or irritation when applied topically or taken orally. Serious adverse effects are not well documented.

Drug interactions

Currently, no substantive clinical evidence details drug interactions with Plantago major. However, caution is advised due to limited data and the potential for unknown interactions with conventional medications. It is recommended to consult a healthcare provider before combining with other drugs.

Who should avoid it

Use should be cautious in populations lacking adequate safety data, such as pregnant or breastfeeding women, or individuals with specific medical conditions. Until more evidence emerges, these groups should seek medical advice before using Plantago major.

Evidence limitations

Most clinical evidence on Plantago major is derived from small randomized controlled trials or observational studies with varying quality and sample sizes. Some systematic reviews note a high risk of bias and methodological shortcomings. Larger, well-designed, multicenter clinical trials are needed to establish clearer efficacy and safety profiles. There is also limited information on appropriate dosing, long-term safety, and drug interactions, especially in special populations.

References

Last reviewed

April 2024

Informational disclaimer: This page is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Plantain (Plantago major) is not approved by the FDA for the treatment of any medical condition. Always consult a qualified healthcare professional before starting any new herbal remedy, particularly if you are pregnant, breastfeeding, have existing medical conditions, or are taking medications.